Ogenix Revenue and Competitors
Estimated Revenue & Valuation
- Ogenix's estimated annual revenue is currently $2.5M per year.
- Ogenix's estimated revenue per employee is $251,000
Employee Data
- Ogenix has 10 Employees.
- Ogenix grew their employee count by -17% last year.
Ogenix's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Operations | Reveal Email/Phone |
3 | Medical Director | Reveal Email/Phone |
4 | Director Podiatric Medicine and Wound Care | Reveal Email/Phone |
Ogenix Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Ogenix?
Ogenix is the manufacturer of EPIFLO, an FDA cleared, 3 ounce, 24/7 oxygen therapy which effectively treats many chronic wounds such as diabetic foot ulcers, venous stasis, pressure sores or bed sores (decubitus), surgical wounds, burns and many others.
keywords:N/AN/A
Total Funding
10
Number of Employees
$2.5M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.8M | 10 | -17% | N/A |
#2 | $0.9M | 10 | N/A | N/A |
#3 | $1.5M | 10 | N/A | N/A |
#4 | $0.9M | 10 | N/A | N/A |
#5 | $1.5M | 10 | N/A | N/A |